Cargando…

The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity

NDRG1 is an oncogenic signaling disruptor that plays a key role in multiple cancers, including aggressive pancreatic tumors. Recent studies have indicated a role for NDRG1 in the inhibition of multiple tyrosine kinases, including EGFR, c-Met, HER2 and HER3, etc. The mechanism of activity of NDRG1 re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chekmarev, Jason, Azad, Mahan Gholam, Richardson, Des R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465210/ https://www.ncbi.nlm.nih.gov/pubmed/34572031 http://dx.doi.org/10.3390/cells10092382

Ejemplares similares

The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1
por: Liu, Wensheng, et al.
Publicado: (2015)

Oncogenic MNK signalling regulates the metastasis suppressor NDRG1
por: Tian, Shuye, et al.
Publicado: (2017)

The Relationship of Glutathione-S-Transferase and Multi-Drug Resistance-Related Protein 1 in Nitric Oxide (NO) Transport and Storage
por: Russell, Tiffany M., et al.
Publicado: (2021)

The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer
por: Lim, Syer C., et al.
Publicado: (2021)

Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells
por: Ghalayini, Mohammad K., et al.
Publicado: (2013)

N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2013)

Correction: N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2016)

Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif
por: You, Guo-Rung, et al.
Publicado: (2022)

NDRG1 is expressed in human granulosa cells: An implicative role of NDRG1 in the ovary
por: Nishigaki, Akemi, et al.
Publicado: (2022)

N-myc downstream regulated gene 1 (ndrg1) functions as a molecular switch for cellular adaptation to hypoxia
por: Park, Jong S, et al.
Publicado: (2022)

NDRG3-mediated lactate signaling in hypoxia
por: Park, Kyung Chan, et al.
Publicado: (2015)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
por: Xu, Shaohua, et al.
Publicado: (2022)

Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer
por: Angst, E, et al.
Publicado: (2006)

Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1
por: Geleta, Bekesho, et al.
Publicado: (2022)

Disruptor: Computational identification of oncogenic mutants disrupting protein-protein and protein-DNA interactions
por: Kugler, Valentina, et al.
Publicado: (2023)

Endocrine disruptors also function as nervous disruptors and can be renamed endocrine and nervous disruptors (ENDs)
por: Seralini, Gilles-Eric, et al.
Publicado: (2021)

Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer
por: Shen, L, et al.
Publicado: (2014)

NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells
por: Kotipatruni, Rama P., et al.
Publicado: (2015)

NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance
por: Hodgson, Rose, et al.
Publicado: (2022)

Synthesis and Activity of Biomimetic Biofilm Disruptors
por: Böttcher, Thomas, et al.
Publicado: (2013)

Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion
por: Ledet, Russell J., et al.
Publicado: (2021)

Bitter Taste Receptors and Endocrine Disruptors: Cellular and Molecular Insights from an In Vitro Model of Human Granulosa Cells
por: Luongo, Francesca Paola, et al.
Publicado: (2022)

NDRG1 protein overexpression in malignant thyroid neoplasms
por: Gerhard, Renê, et al.
Publicado: (2010)

Ndrg1 promotes adipocyte differentiation and sustains their function
por: Cai, Kai, et al.
Publicado: (2017)

NDRG1 in Cancer: A Suppressor, Promoter, or Both?
por: Joshi, Vaibhavi, et al.
Publicado: (2022)

A review on the role of NDRG1 in different cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2023)

The hypoxia-responsive lncRNA NDRG-OT1 promotes NDRG1 degradation via ubiquitin-mediated proteolysis in breast cancer cells
por: Lin, Hsin-Chen, et al.
Publicado: (2017)

The metastasis suppressor, NDRG1, inhibits “stemness” of colorectal cancer via down-regulation of nuclear β-catenin and CD44
por: Wangpu, Xiongzhi, et al.
Publicado: (2015)

NDRG4 promotes myogenesis via Akt/CREB activation
por: Zhu, Mingfei, et al.
Publicado: (2017)

Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)
por: Del Pup, Lino, et al.
Publicado: (2016)

Endocrine Disruptors and Obesity
por: Darbre, Philippa D.
Publicado: (2017)

Endocrine Disruptors and Endometrial Cancer: Molecular Mechanisms of Action and Clinical Implications, a Systematic Review
por: Caserta, Donatella, et al.
Publicado: (2022)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

High expression of NDRG3 in osteoarthritis patients
por: Chen, Long, et al.
Publicado: (2021)

Membrane Hormone Receptors and Their Signaling Pathways as Targets for Endocrine Disruptors
por: Combarnous, Yves, et al.
Publicado: (2022)

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells
por: Watari, Kosuke, et al.
Publicado: (2020)

The effects of actomyosin disruptors on the mechanical integrity of the avian crystalline lens
por: Won, Gah-Jone, et al.
Publicado: (2015)

Comparative Overview of the Mechanisms of Action of Hormones and Endocrine Disruptor Compounds
por: Combarnous, Yves, et al.
Publicado: (2019)

Endocrine disruptors : effects on male and female reproductive systems /
Publicado: (2005)

Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells
por: Li, En-Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h7hsn602ffkmqh00eka06sq4l6